Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
When copper accumulation occurs, symptoms include persistent redness, increased inflammation, skin sensitivity, and paradoxically accelerated aging
Absence of clinical safety data No Phase 1 clinical safety trial for BPC-157 has been completed and published
2020 in Scientific Reports characterized a parallel mechanism through Src-Caveolin-1-eNOS pathway activation, which integrates BPC-157's effects on vasomotor tone with its angiogenic activity in vascular research models
No big RCTs evaluate BPC-157 for fertility outcomes, such as conception, live birth, or enhanced ovarian reserve
Ongoing studies continue to examine cellular communication, angiogenic signaling, cell migration, cytoskeletal organization, extracellular matrix remodeling, and tissue homeostasis
